tiprankstipranks
HilleVax, Inc (HLVX)
NASDAQ:HLVX
US Market

HilleVax, Inc (HLVX) Income Statement

37 Followers

HilleVax, Inc Income Statement

Last quarter (Q4 2023), HilleVax, Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, HilleVax, Inc's net income was $-91.55M. See HilleVax, Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
---$ 0.00$ 0.00
Cost of Revenue
--$ -2.43M--
Gross Profit
--$ 2.43M--
Operating Expense
$ 133.34M$ 133.34M$ -65.11M$ 15.77M$ 1.29M
Operating Income
$ -133.34M$ -133.34M$ -65.11M$ -15.77M$ -1.29M
Net Non Operating Interest Income Expense
$ 7.31M$ 7.31M$ -51.01M$ -2.84M$ -29.00K
Other Income Expense
$ -2.46M$ -2.46M$ 43.69M$ -83.79M$ -779.00K
Pretax Income
$ 89.79M$ 89.79M$ -159.81M$ -102.41M$ -2.10M
Tax Provision
$ -1.29M$ -1.29M$ 1.37M--
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -123.57M$ -123.57M$ -159.81M$ -53.45M$ -2.10M
Basic EPS
$ -3.04$ -3.04$ -5.89$ -3.28$ -0.13
Diluted EPS
$ -3.04$ -3.04$ -5.89$ -3.28$ -0.13
Basic Average Shares
$ 162.39M$ 40.60M$ 27.15M$ 16.29M$ 16.29M
Diluted Average Shares
$ 162.39M$ 40.60M$ 27.15M$ 16.29M$ 16.29M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 133.34M$ 133.34M$ -67.54M$ 15.77M$ 1.29M
Net Income From Continuing And Discontinued Operation
$ -123.57M$ -123.57M$ -159.81M$ -102.41M$ -2.10M
Normalized Income
$ 107.48M$ 89.05M-$ -38.84M$ -2.10M
Interest Expense
---$ 2.84M$ 29.00K
EBIT
$ 92.19M$ 92.19M$ -156.40M$ -99.56M$ -2.07M
EBITDA
$ 67.66M$ 92.01M$ -156.10M$ -99.56M$ -2.07M
Currency in USD

HilleVax, Inc Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis